First line modified Folfirinox versus gemcitabine for advanced pancreatic cancer: A single institution retrospective experience
Author(s) -
Emrah Eraslan,
Fatih Yıldız,
Gülnihal Tufan,
Ferit Aslan,
Umut Demırcı,
Berna Öksüzoğlu
Publication year - 2019
Publication title -
journal of oncological sciences
Language(s) - English
Resource type - Journals
ISSN - 2452-3364
DOI - 10.1016/j.jons.2019.03.002
Subject(s) - gemcitabine , medicine , folfirinox , pancreatic cancer , regimen , oncology , retrospective cohort study , performance status , cancer , gastroenterology , surgery , irinotecan , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom